RE 19 (Atenolol 25 mg)
Pill imprint RE 19 has been identified as Atenolol 25 mg.
Atenolol is used in the treatment of anxiety; high blood pressure; alcohol withdrawal; supraventricular tachycardia; mitral valve prolapse (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RE 19
- 25 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium carbonate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|21695-0322||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about atenolol
- Other brands: Tenormin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.